Addex issued 93 million shares to its wholly owned subsidiary to keep for possible future financing. Shares held outside the company stayed the same, and no completed financing is reported, so the news does not change its outlook.
This gives Addex a way to use the shares in a later financing. The report does not say it has raised cash or completed a financing. Since shares held outside the company did not increase, the change does not alter its outlook today.
Follow Addex Therapeutics (ADXN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ADXN